← Leaderboards
Xiaosi Han
Birmingham Va Medical Center
$1,812,003
Attributed
$2,016,190
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $544.3K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,016,190 · 2
VA$0 · 1
By mechanism
R01$1,607,815 · 1
R21$408,375 · 1
I01$0 · 1
Top collaborators
- Rui Zhao2 shared
Most similar at Birmingham Va Medical Center
Same institution · by research overlap
- Pran K Datta$6,235,645
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantNew Therapeutic TargetStem CellsMolecularCellsGliomagenesisGliomaGrowthGlioblastomaAdultNovel TherapeuticsXenograft ProcedurePathway InteractionsMouse ModelPublishingKnock-DownFight AgainstCancer Stem CellGain Of FunctionAlpha KetoglutarateBrain NeoplasmsEventFamilyGene Expression
Grant awards (9)
Modeling IDH Mutant Gliomas by Genetic Engineering of Brain Organoid$0
I01 · FY2025 · VA · contact PI
Modeling IDH Mutant Gliomas by Genetic Engineering of Brain Organoid$0
I01 · FY2024 · VA · contact PI
Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma$321,563
R01 · FY2019 · NS · contact PI
Modeling low-grade gliomas using human pluripotent stem cells$222,750
R21 · FY2019 · NS
Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma$321,563
R01 · FY2018 · NS · contact PI
Modeling low-grade gliomas using human pluripotent stem cells$185,625
R21 · FY2018 · NS
Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma$321,563
R01 · FY2017 · NS · contact PI
Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma$321,563
R01 · FY2016 · NS · contact PI
Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma$321,563
R01 · FY2015 · NS · contact PI